Science

The war on ‘prediabetes’ could be a boon for pharma—but is it good medicine? | Science

By Charles PillerMar. 7, 2019 , 2:00 PM The most common chronic disease after obesity, afflicting 84 million Americans and more than 1 billion people worldwide, was born as a public relations catchphrase. In 2001, the PR chief of the American Diabetes Association (ADA) approached Richard Kahn, then the group’s chief scientific and medical officer, […]